[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01GA01, streptomycin, Pantoprazole may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Pantoprazole may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Pantoprazole may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Pantoprazole may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Pantoprazole may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N05AL01, sulpiride, The therapeutic efficacy of Sulpiride can be increased when used in combination with Pantoprazole.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Pantoprazole.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Pantoprazole.]
[N05CD07, temazepam, Pantoprazole may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Pantoprazole.]
[R03CC03, terbutaline, Pantoprazole may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Pantoprazole can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03BA03, testosterone, Pantoprazole may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Pantoprazole.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A04AD10, dronabinol, The metabolism of Pantoprazole can be decreased when combined with Dronabinol.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Pantoprazole may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Pantoprazole may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Pantoprazole.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Pantoprazole.]
[G04BE06, moxisylyte, Pantoprazole may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[B03AB03, sodium ironedetate, Pantoprazole can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL03, tiapride, Pantoprazole may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Pantoprazole can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Pantoprazole.]
[P01AB02, tinidazole, Pantoprazole may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Pantoprazole may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Pantoprazole may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Pantoprazole may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N06AF04, tranylcypromine, The metabolism of Pantoprazole can be decreased when combined with Tranylcypromine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Pantoprazole may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Pantoprazole may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Pantoprazole.]
[A03AA05, trimebutine, Pantoprazole may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Pantoprazole.]
[J01EA01, trimethoprim, Pantoprazole may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Pantoprazole.]
[J01FA08, troleandomycin, The metabolism of Pantoprazole can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Pantoprazole.]
[R03DX07, roflumilast, Pantoprazole may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Pantoprazole may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Pantoprazole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Pantoprazole can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Pantoprazole can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Pantoprazole can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The therapeutic efficacy of Rilpivirine can be decreased when used in combination with Pantoprazole.]
[S01AA28, vancomycin, Pantoprazole may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Pantoprazole may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Pantoprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The metabolism of Pantoprazole can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Pantoprazole can be decreased when combined with Viloxazine.]
[L01CA02, vincristine, Pantoprazole may decrease the excretion rate of Vincristine which could result in a higher serum level.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[B01AA03, warfarin, Pantoprazole may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Pantoprazole.]
[J05AE02, indinavir, Pantoprazole can cause a decrease in the absorption of Indinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EC01, vemurafenib, Pantoprazole may decrease the excretion rate of Vemurafenib which could result in a higher serum level.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M05BA05, tiludronic acid, The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Pantoprazole.]
[B06AC02, icatibant, Pantoprazole may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Pantoprazole can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Pantoprazole can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Pantoprazole.]
[M05BA06, ibandronic acid, The therapeutic efficacy of Ibandronate can be decreased when used in combination with Pantoprazole.]
[N05AE04, ziprasidone, The metabolism of Pantoprazole can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Pantoprazole may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Pantoprazole may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Pantoprazole may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Pantoprazole.]
[J02AC03, voriconazole, The metabolism of Pantoprazole can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Pantoprazole may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Pantoprazole.]
[B03XA04, peginesatide, Pantoprazole may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Pantoprazole may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Pantoprazole may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Pantoprazole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Pantoprazole may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Pantoprazole.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A08AA11, lorcaserin, Pantoprazole may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Pantoprazole may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, The metabolism of Pantoprazole can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Pantoprazole can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Pantoprazole can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, Pantoprazole can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA31, teriflunomide, Pantoprazole may decrease the excretion rate of Teriflunomide which could result in a higher serum level.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Pantoprazole.]
[D02BA02, octinoxate, Pantoprazole may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The serum concentration of Nelfinavir can be decreased when it is combined with Pantoprazole.]
[N04BD02, rasagiline, Pantoprazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[N06DA02, donepezil, Pantoprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Pantoprazole may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The metabolism of Pantoprazole can be decreased when combined with Sildenafil.]
[V08CA11, gadofosveset, Pantoprazole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, Pantoprazole may decrease the excretion rate of Ponatinib which could result in a higher serum level.]
[B01AF02, apixaban, Pantoprazole may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[A16AX08, teduglutide, Pantoprazole may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Pantoprazole may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Pantoprazole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Pantoprazole may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M04AB03, benzbromarone, The metabolism of Pantoprazole can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, Pantoprazole may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Pantoprazole.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Pantoprazole.]
[L03AA12, ancestim, Pantoprazole may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Pantoprazole may decrease the excretion rate of Celecoxib which could result in a higher serum level.]
[N04AC01, benztropine, Pantoprazole may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Pantoprazole can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01EE01, trametinib, Pantoprazole may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Pantoprazole may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[B03AB04, ferric hydroxide, Pantoprazole can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EB03, afatinib, Pantoprazole may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[N06AX28, levomilnacipran, Pantoprazole may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, Pantoprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C02KX05, riociguat, Pantoprazole can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BJ03, lixisenatide, Pantoprazole may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Pantoprazole.]
[C02KX04, macitentan, Pantoprazole may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Pantoprazole.]
[G03AC08, etonogestrel, Pantoprazole may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The metabolism of Pantoprazole can be decreased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Pantoprazole can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Pantoprazole can be decreased when combined with Simeprevir.]
[V03AE05, sucroferric oxyhydroxide, Pantoprazole can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AP08, sofosbuvir, Pantoprazole may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Pantoprazole may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Pantoprazole may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Pantoprazole can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Pantoprazole can be increased when combined with Apremilast.]
[L02BG02, formestane, Pantoprazole may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Pantoprazole may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Pantoprazole can be increased when combined with Siltuximab.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Pantoprazole.]
[L01EM01, idelalisib, Pantoprazole may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[V08AA01, diatrizoic acid, Pantoprazole may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V03AE01, polystyrene sulfonate, The therapeutic efficacy of Tolevamer can be decreased when used in combination with Pantoprazole.]
[V08AA04, iothalamic acid, Pantoprazole may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[J01XA05, oritavancin, The metabolism of Pantoprazole can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Pantoprazole.]
[V03AE08, ferric citrate, Pantoprazole can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Pantoprazole.]
[S03AA06, gentamicin, Pantoprazole may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Pantoprazole may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L04AC10, secukinumab, The metabolism of Pantoprazole can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The absorption of Palbociclib can be decreased when combined with Pantoprazole.]
[L01EX08, lenvatinib, Pantoprazole may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[N02BE01, acetaminophen, Pantoprazole may decrease the excretion rate of Acetaminophen which could result in a higher serum level.]
[L01DC01, bleomycin, Pantoprazole may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AP06, asunaprevir, Pantoprazole can cause a decrease in the absorption of Asunaprevir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Pantoprazole.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The metabolism of Pantoprazole can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Pantoprazole may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Pantoprazole.]
[J02AC05, isavuconazole, The metabolism of Pantoprazole can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Pantoprazole may decrease the excretion rate of Osimertinib which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Pantoprazole.]
[L01XG03, ixazomib, Pantoprazole may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, The excretion of Selexipag can be decreased when combined with Pantoprazole.]
[M04AB05, lesinurad, Pantoprazole may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP11, grazoprevir, The excretion of Grazoprevir can be decreased when combined with Pantoprazole.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N03AX23, brivaracetam, Pantoprazole may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Pantoprazole can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Pantoprazole may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Pantoprazole may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Pantoprazole.]
[N01BB01, bupivacaine, Pantoprazole may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N07BC01, buprenorphine, The metabolism of Pantoprazole can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Pantoprazole may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Pantoprazole may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Pantoprazole.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Pantoprazole.]
[L01XK03, rucaparib, Pantoprazole may decrease the excretion rate of Rucaparib which could result in a higher serum level.]
[L01EF02, ribociclib, The metabolism of Pantoprazole can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A06AH05, naldemedine, Pantoprazole may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Pantoprazole may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pantoprazole may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[P01CA02, benznidazole, Pantoprazole may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Pantoprazole may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Pantoprazole can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Pantoprazole may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Pantoprazole can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Pantoprazole can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, Pantoprazole may decrease the excretion rate of Brigatinib which could result in a higher serum level.]
[J01MA23, delafloxacin, Pantoprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Pantoprazole may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, Pantoprazole may decrease the excretion rate of Enasidenib which could result in a higher serum level.]
[L01EM02, copanlisib, Pantoprazole may decrease the excretion rate of Copanlisib which could result in a higher serum level.]
[L01EF03, abemaciclib, Pantoprazole may decrease the excretion rate of Abemaciclib which could result in a higher serum level.]
[C07AB07, bisoprolol, Pantoprazole may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Pantoprazole can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Pantoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AX18, letermovir, The metabolism of Pantoprazole can be increased when combined with Letermovir.]
[A10BK04, ertugliflozin, Pantoprazole may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[R06AX18, acrivastine, Pantoprazole may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, Pantoprazole can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L02BB05, apalutamide, The serum concentration of Pantoprazole can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Pantoprazole can be increased when combined with Carbamazepine.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Pantoprazole.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Pantoprazole.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Pantoprazole.]
[J01GB14, plazomicin, Pantoprazole may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[H01CC03, elagolix, The excretion of Elagolix can be decreased when combined with Pantoprazole.]
[L01XX62, ivosidenib, The metabolism of Pantoprazole can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Pantoprazole may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Pantoprazole can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Pantoprazole may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AX24, tecovirimat, The metabolism of Pantoprazole can be decreased when combined with Tecovirimat.]
[L01EM04, duvelisib, Pantoprazole may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, Pantoprazole can cause a decrease in the absorption of Dacomitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01GX12, cetirizine, Pantoprazole may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Pantoprazole may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01XK04, talazoparib, Pantoprazole may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Pantoprazole.]
[R03BB08, revefenacin, Pantoprazole may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Pantoprazole can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Pantoprazole may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[L01XJ03, glasdegib, Pantoprazole may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[A06AX05, prucalopride, Pantoprazole may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Pantoprazole.]
[P02BX04, triclabendazole, The metabolism of Pantoprazole can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Pantoprazole.]
[N06BA14, solriamfetol, Pantoprazole may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Pantoprazole.]
[L04AB01, etanercept, The metabolism of Pantoprazole can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Pantoprazole.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Pantoprazole.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Pantoprazole.]
[L02BB06, darolutamide, Pantoprazole may decrease the excretion rate of Darolutamide which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01EX15, pexidartinib, The serum concentration of Pexidartinib can be decreased when it is combined with Pantoprazole.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Pantoprazole.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Pantoprazole.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[S01AA27, cefuroxime, The serum concentration of Cefuroxime can be decreased when it is combined with Pantoprazole.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Pantoprazole.]
[N07XX11, pitolisant, The serum concentration of Pantoprazole can be decreased when it is combined with Pitolisant.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Pantoprazole.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Pantoprazole.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Pantoprazole.]
[N03AX25, cenobamate, The serum concentration of Pantoprazole can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M09AX08, golodirsen, Pantoprazole may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Pantoprazole.]
[S01XA12, dexpanthenol, Pantoprazole may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01XX72, tazemetostat, Pantoprazole may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Pantoprazole.]
[H02CA02, osilodrostat, The metabolism of Pantoprazole can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Pantoprazole can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, Pantoprazole may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, Pantoprazole may decrease the excretion rate of Selumetinib which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Pantoprazole may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Pantoprazole may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C08CA16, clevidipine, The metabolism of Pantoprazole can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Pantoprazole can be decreased when combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Pantoprazole can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Pantoprazole.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01EX19, ripretinib, Pantoprazole may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[V08CA05, mangafodipir, Pantoprazole may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Pantoprazole.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AX29, fostemsavir, Pantoprazole may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Pantoprazole.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Pantoprazole.]
[L04AC19, satralizumab, The serum concentration of Pantoprazole can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Pantoprazole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, Pantoprazole may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Pantoprazole may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.]
[A10BB02, chlorpropamide, Pantoprazole may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Pantoprazole may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Pantoprazole.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N02BA03, choline salicylate, Pantoprazole may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Pantoprazole.]
[A16AX20, lonafarnib, The metabolism of Pantoprazole can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Pantoprazole may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Pantoprazole can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, Pantoprazole may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The metabolism of Pantoprazole can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C01CA19, fenoldopam, Pantoprazole may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[V08CA07, ferric ammonium citrate, Pantoprazole can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V03AB31, prussian blue insoluble, Pantoprazole can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AB02, iron sucrose, Pantoprazole can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA02, ferrous fumarate, Pantoprazole can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA03, ferrous gluconate, Pantoprazole can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA06, ferrous succinate, Pantoprazole can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B03AA07, ferrous sulfate, Pantoprazole can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Pantoprazole.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Pantoprazole.]
[N02BG07, flupirtine, Pantoprazole may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Pantoprazole.]
[B03AB10, ferric maltol, Pantoprazole can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Pantoprazole.]
[V08CA04, gadoteridol, Pantoprazole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[L01XX73, sotorasib, The therapeutic efficacy of Sotorasib can be decreased when used in combination with Pantoprazole.]
[L01EN03, infigratinib, The serum concentration of Infigratinib can be decreased when it is combined with Pantoprazole.]
[S03AA07, ciprofloxacin, The metabolism of Pantoprazole can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Pantoprazole may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Pantoprazole is combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Pantoprazole can be decreased when combined with Somapacitan.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Pantoprazole.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Pantoprazole.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Pantoprazole.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Pantoprazole.]
[V09AB03, ioflupane I-123, Pantoprazole may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Pantoprazole may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Pantoprazole may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N06AX25, St. John's wort extract, The metabolism of Pantoprazole can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Pantoprazole can be decreased when combined with Asciminib.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Pantoprazole.]
[N01BB10, levobupivacaine, Pantoprazole may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N06AA04, clomipramine, The metabolism of Pantoprazole can be decreased when combined with Clomipramine.]
[N03AE01, clonazepam, Pantoprazole may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Pantoprazole.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Pantoprazole.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Pantoprazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Pantoprazole can be decreased when combined with Vonoprazan.]
[N05AH02, clozapine, The metabolism of Pantoprazole can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Pantoprazole may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Pantoprazole can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Pantoprazole can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M04AC01, colchicine, Pantoprazole may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Pantoprazole may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L04AA13, leflunomide, Pantoprazole may decrease the excretion rate of Leflunomide which could result in a higher serum level.]
[A04AA03, tropisetron, Pantoprazole may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Pantoprazole may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Pantoprazole can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AB14, valganciclovir, Pantoprazole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Pantoprazole may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Pantoprazole may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Pantoprazole may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Pantoprazole may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Pantoprazole may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N02CC05, almotriptan, Pantoprazole may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J02AC02, itraconazole, Pantoprazole can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Pantoprazole.]
[N05BA10, ketazolam, Pantoprazole may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01EA01, imatinib, Pantoprazole may decrease the excretion rate of Imatinib which could result in a higher serum level.]
[J02AC04, posaconazole, Pantoprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Pantoprazole.]
[N03AX09, lamotrigine, Pantoprazole may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Pantoprazole may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C09AA03, lisinopril, Pantoprazole may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Pantoprazole may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Pantoprazole can be decreased when combined with Manidipine.]
[J01DH02, meropenem, Pantoprazole may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Pantoprazole may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Pantoprazole.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Pantoprazole.]
[S01XA18, cyclosporine, The metabolism of Pantoprazole can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Pantoprazole.]
[N06BA07, modafinil, The metabolism of Pantoprazole can be decreased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Pantoprazole.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[S01XA21, cysteamine, The bioavailability of Cysteamine can be decreased when combined with Pantoprazole.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Pantoprazole can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, The metabolism of Pantoprazole can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, Pantoprazole may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[L01DA01, dactinomycin, Pantoprazole may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Pantoprazole can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, Pantoprazole may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N07BB05, nalmefene, Pantoprazole may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Pantoprazole.]
[S01GX04, nedocromil, Pantoprazole may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Pantoprazole can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Pantoprazole may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Pantoprazole.]
[B01AX05, fondaparinux, Pantoprazole may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Pantoprazole.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N06AA01, desipramine, Pantoprazole may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[V04CH02, indigo carmine, Pantoprazole may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Pantoprazole may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[L01XA03, oxaliplatin, Pantoprazole may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Pantoprazole can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Pantoprazole can be increased when combined with Dexamethasone.]
[L04AB04, adalimumab, The metabolism of Pantoprazole can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Pantoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06BA02, dextroamphetamine, Pantoprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Pantoprazole.]
[B01AC04, clopidogrel, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Pantoprazole resulting in a loss in efficacy.]
[P03AC04, permethrin, Pantoprazole may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Pantoprazole.]
[R05DA08, pholcodine, Pantoprazole may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The therapeutic efficacy of Clodronic acid can be decreased when used in combination with Pantoprazole.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A03AA07, dicyclomine, Pantoprazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Pantoprazole may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01EB02, erlotinib, Pantoprazole can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, The metabolism of Pantoprazole can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, Pantoprazole may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C01AA05, digoxin, Pantoprazole may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, Pantoprazole may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[N02AA03, hydromorphone, Pantoprazole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Pantoprazole may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The therapeutic efficacy of Atazanavir can be decreased when used in combination with Pantoprazole.]
[H03BC01, potassium perchlorate, Pantoprazole may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pantoprazole may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Pantoprazole can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Pantoprazole may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Pantoprazole can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Pantoprazole.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Pantoprazole.]
[N06BA11, dexmethylphenidate, Pantoprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[S01AX06, resorcinol, Pantoprazole may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Pantoprazole may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[S02AA12, rifamycin SV, The metabolism of Pantoprazole can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Pantoprazole can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Pantoprazole may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[R06AE09, levocetirizine, Pantoprazole may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Pantoprazole may decrease the excretion rate of Ropivacaine which could result in a higher serum level.]
[A04AD12, aprepitant, The metabolism of Pantoprazole can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Pantoprazole can be decreased when combined with Bortezomib.]
[J05AE07, fosamprenavir, Pantoprazole can cause a decrease in the absorption of Fosamprenavir resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BE08, tadalafil, Pantoprazole may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C02KX02, ambrisentan, The excretion of Ambrisentan can be decreased when combined with Pantoprazole.]
[C01EB18, ranolazine, Pantoprazole may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C01CA07, dobutamine, Pantoprazole may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Pantoprazole may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Pantoprazole can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Pantoprazole.]
[L01DB01, doxorubicin, Pantoprazole may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[J01AA02, doxycycline, Pantoprazole can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Pantoprazole.]
[A08AA10, sibutramine, Pantoprazole may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The excretion of Simvastatin can be decreased when combined with Pantoprazole.]
[A12CA02, sodium sulfate, Pantoprazole may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Pantoprazole may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Pantoprazole may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Pantoprazole may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Pantoprazole.]
[L01AX03, temozolomide, Pantoprazole may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C09AA02, enalapril, The excretion of Enalapril can be decreased when combined with Pantoprazole.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N06AG03, toloxatone, Pantoprazole may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Pantoprazole may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, The metabolism of Pantoprazole can be decreased when combined with Topiramate.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Pantoprazole may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N06AX16, venlafaxine, Pantoprazole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CA12, mepirodipine, The metabolism of Pantoprazole can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Pantoprazole.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C02AC02, guanfacine, Pantoprazole may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[N02CA02, ergotamine, The metabolism of Pantoprazole can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Pantoprazole.]
[L03AX05, pidotimod, Pantoprazole may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Pantoprazole can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Pantoprazole may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Pantoprazole can be decreased when combined with Fusidic acid.]
[S02BA08, fluocinolone acetonide, Pantoprazole may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pantoprazole may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Pantoprazole.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Pantoprazole.]
[J04AK02, ethambutol, The metabolism of Pantoprazole can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The excretion of Fluvastatin can be decreased when combined with Pantoprazole.]
[V08CA03, gadodiamide, Pantoprazole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The metabolism of Pantoprazole can be decreased when combined with Ethinylestradiol.]
[C01BD05, ibutilide, Pantoprazole may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N01AX07, etomidate, Pantoprazole may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L01CB01, etoposide, Pantoprazole may decrease the excretion rate of Etoposide which could result in a higher serum level.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Pantoprazole.]
[R06AX12, terfenadine, The metabolism of Pantoprazole can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Pantoprazole may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Pantoprazole may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Pantoprazole can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Pantoprazole.]
[M01CB01, gold sodium thiomalate, Pantoprazole may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Pantoprazole may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Pantoprazole may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Pantoprazole.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Pantoprazole.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Pantoprazole.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N02AB03, fentanyl, Pantoprazole may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Pantoprazole may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Pantoprazole.]
[L04AA40, cladribine, Pantoprazole may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G04BD02, flavoxate, Pantoprazole may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Pantoprazole can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Pantoprazole may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Pantoprazole may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[V03AZ01, ethanol, The metabolism of Pantoprazole can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, Pantoprazole may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[L01BC02, fluorouracil, Pantoprazole may decrease the excretion rate of Fluorouracil which could result in a higher serum level.]
[N06AB03, fluoxetine, The metabolism of Pantoprazole can be decreased when combined with Fluoxetine.]
[N05CD01, flurazepam, Pantoprazole may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L02BB01, flutamide, Pantoprazole may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Pantoprazole may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Pantoprazole may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L01BC03, tegafur, Pantoprazole may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[J05AE10, darunavir, The metabolism of Pantoprazole can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Pantoprazole may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[S01AD09, ganciclovir, Pantoprazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, The metabolism of Pantoprazole can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Pantoprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Pantoprazole can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Pantoprazole.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Pantoprazole.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Pantoprazole.]
[A10BB01, glyburide, Pantoprazole may decrease the excretion rate of Glyburide which could result in a higher serum level.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Pantoprazole.]
[A10BB07, glipizide, Pantoprazole may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Pantoprazole may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Pantoprazole.]
[L01EX02, sorafenib, Pantoprazole may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[M01CB04, aurothioglucose, Pantoprazole may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pantoprazole may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Pantoprazole may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Pantoprazole may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Pantoprazole.]
[N05AH04, quetiapine, Pantoprazole may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Pantoprazole may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, Pantoprazole may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Pantoprazole.]
[C09CA01, losartan, The metabolism of Pantoprazole can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, Pantoprazole may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Pantoprazole can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C01CE02, milrinone, Pantoprazole may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Pantoprazole.]
[C08CA10, nilvadipine, The metabolism of Pantoprazole can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C09AA04, perindopril, Pantoprazole may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Pantoprazole may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Pantoprazole.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Pantoprazole.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Pantoprazole may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G04BD06, propiverine, Pantoprazole may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Pantoprazole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[J04AB04, rifabutin, The metabolism of Pantoprazole can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, Pantoprazole can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[B05XA08, sodium acetate, Pantoprazole may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Pantoprazole may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, The metabolism of Pantoprazole can be decreased when combined with Imipramine.]
[R01AD07, tixocortol, Pantoprazole may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Pantoprazole may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Pantoprazole.]
[A11HA07, inositol, Pantoprazole may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Pantoprazole can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Pantoprazole may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Pantoprazole.]
[N05BA12, alprazolam, Pantoprazole may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Pantoprazole.]
[C10AA06, cerivastatin, Pantoprazole may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Pantoprazole may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Pantoprazole.]
[J04AC01, isoniazid, The metabolism of Pantoprazole can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Pantoprazole may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Pantoprazole may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[P02CF01, ivermectin, Pantoprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[S01AA24, kanamycin, Pantoprazole may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Pantoprazole can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Pantoprazole may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Pantoprazole may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, Pantoprazole can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AH03, olanzapine, The metabolism of Pantoprazole can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L04AA24, abatacept, The metabolism of Pantoprazole can be increased when combined with Abatacept.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Pantoprazole.]
[N04BB01, amantadine, Pantoprazole may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Pantoprazole may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Pantoprazole.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA21, amikacin, Pantoprazole may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Pantoprazole can be decreased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Pantoprazole can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Pantoprazole.]
[B05XA11, magnesium chloride, Pantoprazole may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Pantoprazole may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Pantoprazole may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Nilotinib can be decreased when it is combined with Pantoprazole.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Pantoprazole may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Pantoprazole may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Pantoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Pantoprazole may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Pantoprazole can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Pantoprazole.]
[N01BB03, mepivacaine, Pantoprazole may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Pantoprazole may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Pantoprazole may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Pantoprazole may decrease the excretion rate of Metformin which could result in a higher serum level.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Pantoprazole.]
[N06BA03, methamphetamine, Pantoprazole may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Pantoprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX05, methenamine, The therapeutic efficacy of Methenamine can be decreased when used in combination with Pantoprazole.]
[H03BB02, methimazole, The metabolism of Pantoprazole can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Pantoprazole may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Pantoprazole.]
[D05BA02, methoxsalen, Pantoprazole may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Pantoprazole may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Pantoprazole.]
[N06BA04, methylphenidate, Pantoprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[G03EK01, methyltestosterone, Pantoprazole may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Pantoprazole may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Pantoprazole may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[V04CD01, metyrapone, Pantoprazole may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[S02AA13, miconazole, The metabolism of Pantoprazole can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N05CD08, midazolam, Pantoprazole may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[J05AH01, zanamivir, Pantoprazole may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, The excretion of Valsartan can be decreased when combined with Pantoprazole.]
[L01XX23, mitotane, The metabolism of Pantoprazole can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, Pantoprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Pantoprazole can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Pantoprazole.]
[A04AA05, palonosetron, Pantoprazole may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Pantoprazole can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Pantoprazole may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, Pantoprazole can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA06, mycophenolic acid, Pantoprazole can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AJ01, raltegravir, Pantoprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[G03XC01, raloxifene, Pantoprazole may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N03AB05, fosphenytoin, The metabolism of Pantoprazole can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Pantoprazole may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[V03AB15, naloxone, The metabolism of Pantoprazole can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Pantoprazole can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Pantoprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N06AX21, duloxetine, Pantoprazole may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Pantoprazole may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[L02BG04, letrozole, The metabolism of Pantoprazole can be decreased when combined with Letrozole.]
[S03AA01, neomycin, Pantoprazole may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, The excretion of Repaglinide can be decreased when combined with Pantoprazole.]
[B01AC17, tirofiban, Pantoprazole may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[S01AA19, ampicillin, Pantoprazole may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Pantoprazole may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Pantoprazole may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Pantoprazole can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, The metabolism of Pantoprazole can be decreased when combined with Telmisartan.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Pantoprazole.]
[C01CE01, inamrinone, Pantoprazole may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C08CA04, nicardipine, The metabolism of Pantoprazole can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Pantoprazole may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C08CA07, nisoldipine, Pantoprazole may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Pantoprazole may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Pantoprazole may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Pantoprazole may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pantoprazole may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Pantoprazole may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[C02KX01, bosentan, The excretion of Bosentan can be decreased when combined with Pantoprazole.]
[H01CB02, octreotide, Pantoprazole can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC04, rilonacept, The metabolism of Pantoprazole can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Pantoprazole.]
[N02AA02, opium, Pantoprazole may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Pantoprazole may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Pantoprazole.]
[J01CF04, oxacillin, Pantoprazole may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[V08CB01, ferumoxsil, Pantoprazole can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05BA04, oxazepam, Pantoprazole may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Pantoprazole.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Pantoprazole.]
[J04AB30, capreomycin, Pantoprazole may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G04BD11, fesoterodine, Pantoprazole may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Pantoprazole may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The excretion of Penicillamine can be decreased when combined with Pantoprazole.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Pantoprazole.]
[J01CE09, penicillin G procaine, Pantoprazole may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Pantoprazole can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Pantoprazole may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pantoprazole may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N06AF03, phenelzine, Pantoprazole may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[N03AA02, phenobarbital, The metabolism of Pantoprazole can be increased when combined with Phenobarbital.]
[V03AB36, phentolamine, Pantoprazole may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Pantoprazole.]
[N03AB02, phenytoin, The metabolism of Pantoprazole can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Pantoprazole can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Pantoprazole may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Pantoprazole.]
[B02BA01, vitamin K1, Pantoprazole may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[C07AA03, pindolol, Pantoprazole may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[C10AA05, atorvastatin, The excretion of Atorvastatin can be decreased when combined with Pantoprazole.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Pantoprazole.]
[J05AE01, saquinavir, The risk or severity of adverse effects can be increased when Pantoprazole is combined with Saquinavir.]
[N06BX03, piracetam, Pantoprazole may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J01DD16, cefditoren, The serum concentration of Cefditoren can be decreased when it is combined with Pantoprazole.]
[J05AG02, delavirdine, Pantoprazole can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A10BG02, rosiglitazone, Pantoprazole may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[L04AC08, canakinumab, The metabolism of Pantoprazole can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Pantoprazole.]
[J05AE03, ritonavir, The serum concentration of Pantoprazole can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Pantoprazole.]
[B05XA01, potassium chloride, Pantoprazole may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C10AA08, pitavastatin, Pantoprazole may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Pantoprazole.]
[C02CA01, prazosin, Pantoprazole may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[H02AB07, prednisone, Pantoprazole may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Pantoprazole can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Pantoprazole can be increased when combined with Primidone.]
[M04AB01, probenecid, Pantoprazole may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Pantoprazole may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[C10AB05, fenofibrate, The metabolism of Pantoprazole can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Pantoprazole.]
[R06AD02, promethazine, Pantoprazole may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Pantoprazole may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Pantoprazole.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Pantoprazole.]
[N02CC04, rizatriptan, Pantoprazole may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Pantoprazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Pantoprazole may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Pantoprazole may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pantoprazole may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Pantoprazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Pantoprazole.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Pantoprazole.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AP01, ribavirin, Pantoprazole may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, Pantoprazole can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[A07EC01, sulfasalazine, Pantoprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[N05CA06, secobarbital, Pantoprazole may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[J01GB08, sisomicin, Pantoprazole may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Pantoprazole may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Pantoprazole may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA01, etidronic acid, The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Pantoprazole.]
[M05BA04, alendronic acid, The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Pantoprazole.]
[C01DA14, isosorbide mononitrate, Pantoprazole may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[H02CA04, levoketoconazole, Pantoprazole can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[D10AX03, azelaic acid, Pantoprazole may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir - proton pump inhibitors (PPIs)]
